What does a PCN pharmacist do?
The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary […]
The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary […]
The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist […]
The EU drug regulator, the European Medicines Agency (EMA), has a beefed-up budget for 2022 and plans to grow further in the years ahead. The watchdog’s Management Board […]
The European Medicines Agency (EMA) has authorised several new therapies and vaccines for COVID-19 which offer fresh hope of containing the two-year old pandemic, the EU drug watchdog […]
Thirteen new medicines were given the green light at the December meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP). This brings to […]
Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed […]
Natural cannabidiol distillate is superior to synthetic CBD because of the benefits of the ‘entourage effect’, according to Moyra Cosgrove, Head of Nutrition for Naturecan, a company that […]
There is a growing body of evidence for the effectiveness of cannabidiol (CBD) in a number of health conditions. To find out more, IMI spoke to Moyra Cosgrove, […]
Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine. A […]
A global call to action issued by the International Pharmaceutical Federation (FIP) on 13th December 2021 sets out 18 urgent actions needed from academic institutions, professional organisations, policymakers […]
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]
A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session […]
ADVERTISMENT